B8F — Biofrontera AG Cashflow Statement
0.000.00%
Last trade - 00:00
- €21.82m
- €19.61m
- €25.74m
- 36
- 63
- 15
- 28
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -19.3 | -4.78 | -12.7 | 35.7 | -43.2 |
Depreciation | |||||
Non-Cash Items | 3 | -13.8 | 6.3 | -12.6 | 44 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 2.08 | -17.5 | -1.78 | 4.05 | -5.39 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -13.4 | -32.9 | -2.85 | 30.4 | -3.9 |
Capital Expenditures | -0.513 | -1.85 | -0.774 | -0.629 | -0.981 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 0.002 | 22.9 | 3.65 | -41.6 | 0 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -0.511 | 21.1 | 2.87 | -42.3 | -0.981 |
Financing Cash Flow Items | -2.3 | -0.667 | -1.19 | -6.86 | -0.262 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 22.3 | 3.46 | 5.95 | 2.18 | 4.34 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 8.37 | -8.33 | 5.43 | -9.64 | -0.532 |